{"disease":{"id":"unresectable-locally-advanced-pancreatic-carcinoma","name":"unresectable locally advanced pancreatic carcinoma"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03003078","title":"A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane","phase":"NA","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"OncoSil Medical Limited","has_results":false},{"nct_id":"NCT03076216","title":"A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel.","phase":"NA","overall_status":"COMPLETED","enrollment_count":9,"lead_sponsor_name":"OncoSil Medical Limited","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}